When was Qureight founded?

Qureight was founded in 2018 and raised its 1st funding round 3 years after it was founded.

Where is Qureight located?

Qureight is headquartered in Cambridge, United Kingdom. It is registered at C/O Watermill Accounting Ltd Future Business Centre, Kings Hedges Road, Cambridge, United Kingdom, CB4 2HY.

Which legal entities is Qureight associated with?

Qureight is associated with QUREIGHT LIMITED.

How many employees does Qureight have?

As of Jul 31, 2026, the latest employee count at Qureight is 61.

Is Qureight a funded company?

Qureight is a funded company, having raised a total of $31.2M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Sep 24, 2021.

When was the latest funding round of Qureight?

Qureight's latest funding was a $***** Series B round on Jul 29, 2026, with participation from 6 investors.

Where does Qureight rank among its competitors?

Qureight ranks 7th amongst 122 active competitors, of which 21 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Qureight, which secured $20M in Jul, 2026.

Who are the top competitors of Qureight?

Qureight's top competitors include Manifold AI, Komodo Health and Owkin. Among them, Qureight secured the most recent funding round in July, 2026.

Qureight - 2026 Company Profile, Funding, Competitors & Financials

Qureight is a series B company based in Cambridge (United Kingdom), founded in 2018. It operates as an AI enabled data curation platform for drug development. Qureight has raised $31.2M in funding from investors like CMS Ventures, Hargreave Hale VCTs and Molten Ventures. The company has 122 active competitors, including 21 funded and 4 that have exited. Its top competitors include companies like Manifold AI, Komodo Health and Owkin.

Company Details

AI enabled data curation platform for drug development. It specializing in AI-powered data and imaging curation to advance understanding of lung and heart diseases, accelerating drug development through clinical trials, new endpoints, and synthetic control arms.

Website: www.qureight.com
Social
Registered Address: C/O Watermill Accounting Ltd Future Business Centre, Kings Hedges Road, Cambridge, United Kingdom, CB4 2HY

Key Metrics

Founded Year

2018

Location

Cambridge, United Kingdom

Stage

Series B

Total Funding

$31.2M in 4 rounds

Latest Funding Round

Series B, Jul 29, 2026, $*****

Investors

CMS Ventures & 22 more

Ranked

7^th among 122 active competitors

Employee Count

61 as on Jul 31, 2026

Similar Companies

OpenEvidence & 2456 more

View Qureight's full profile

Qureight is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
QUREIGHT LIMITED CIN: 11132399 , United Kingdom, Active	Jan 03, 2018	-	17 (As on Dec 31, 2024)

Qureight has raised a total funding of $31.2M over 4 rounds. Its first funding round was on Sep 24, 2021. Its latest funding round was a Series B round on Jul 29, 2026 for $*****. 6 investors participated in its latest round. Qureight has 15 institutional investors and 8 angel investors.

Here is the list of recent funding rounds of Qureight:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 29, 2026	5245586	Series B	1953472	6601028	8793253	3843515
Apr 16, 2024	1242155	Series A	5697892	5395139	3251033	XTX Markets & 5 more
Feb 01, 2022	1828597	Seed	3267304	4127909	Playfair Capital	Meltwind Advisory & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Qureight's funding rounds and investors

Qureight's employee count trend

Qureight has 61 employees as of Jul 26. Here is Qureight's employee count trend over the years:

Uncover Qureight's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Qureight include Manifold AI, Komodo Health and Owkin. Here is the list of Top 10 competitors of Qureight, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Manifold AI 2016, Oakland (United States), Series B	Provider of an AI platform for life sciences research and development	$40M	TQ Ventures, Reach Capital & 13 others	71/100
2nd	Komodo Health 2014, New York City (United States), Series E	AI and cloud-based platforms provide data-driven insights to healthcare providers	$514M	Tiger Global Management, Andreessen Horowitz ... & 14 others	71/100
3rd	Owkin 2016, Paris (France), Series B	AI generative biology company to create the new standard of biology reasoning	$321M	F-Prime Capital, Google Ventures & 18 others	71/100
4th	Clarify 2015, San Francisco (United States), Series D	Company provides healthcare analytics and value-based payments platform services	$411M	Insight Partners, SoftBank Vision Fund & 22 others	64/100
5th	Apheris 2019, Berlin (Germany), Series A	Provider of data analytics solutions for life science industry	$20.8M	LocalGlobe, OTB Ventures & 16 others	60/100
6th	Reliant AI 2023, Montreal (Canada), Acquired	Provider of an AI platform for biopharmaceutical research and development	$13.5M	Tola Capital, Inovia Capital & 5 others	58/100
7th	Qureight 2018, Cambridge (United Kingdom), Series B	AI enabled data curation platform for drug development	$31.2M	Molten Ventures, Playfair Capital & 21 others	57/100
8th	Seven Bridges Genomics 2009, Cambridge (United States), Acquired	Biomedical data analysis company accelerating healthcare research with software and analytics	$113M	First Star Ventures, Western Technology Investment ... & 3 others	54/100
9th	Sequencing.com 2014, Los Angeles (United States), Series A	Developer of technology that integrates genetic data into software applications	$5M	Lerer Hippeau, Global Founders Capital & 10 others	52/100
10th	Rivia 2002, Switzerland, Series A	Provider of an AI-powered data analytics platform for clinical trials	$18.2M	Speedinvest, Earlybird & 3 others	52/100